Top Markets
#1 Black Phoenix Black Phoenix +828.57%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.40%
#3 Beam Beam +23.21%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +22.56%
#5 SAFEcoin SAFEcoin +20.80%
#6 Magma Finance Magma Finance +20.11%
#7 pipedog pipedog +18.82%
#8 Bless Bless +16.88%
#9 PondCoin PondCoin +16.70%
#10 THORChain THORChain +16.34%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
Rank in Stocks #5977
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Share Price
$45.12
Market Cap
$2.29B
Change (1 day)
9.82%
Change (1 year)
400.72%
Country
FR
Trade Nanobiotix S.A. (NANO)

Category

Healthcare
Stock price history for Nanobiotix S.A. (NANO)
Highest end of day price: $41.65 on 2026-08-01

Lowest end of day price: $8.60 on 2012-10-01
Stock price history of Nanobiotix S.A. from 2012 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 29.51%
2025 582.51%
2024 -45.85%
2023 51.22%
2022 -50.99%
2021 -50.84%
2020 93.52%
2019 -37.58%
2018 -11.94%
2017 -7.30%
2016 -2.69%
2015 -15.40%
2014 172.96%
2013 -14.45%
2012 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.88 41.07%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.71%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.94 461.51%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH